Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Marwan G Fakih

27PUBLICATIONS
174CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

Sort by Publication Date:
|May 18, 2026
EXONERATE-TRaCE: A Liquid Biopsy for Tracking Response to Anti-Epidermal Growth Factor Receptor-Based Therapy in Metastatic Colorectal Cancer.

|Feb 27, 2026
Utility of Circulating Tumor DNA to Assess Tumor Response in Patients with Locally Advanced Rectal Cancer Undergoing Neoadjuvant Therapy.

Sakti Chakrabarti, Stacey A Cohen, Antony Tin

|Feb 20, 2026
Baseline Tumor Features and Systemic Immune Dynamics Underlying Efficacy in MSS Metastatic Colorectal Cancer Treated with Regorafenib, Ipilimumab, and Nivolumab.

Jian Ye, Chongkai Wang, Colt A Egelston

|Apr 11, 2025
Overall Survival Analysis of the Phase III CodeBreaK 300 Study of Sotorasib Plus Panitumumab Versus Investigator's Choice in Chemorefractory <i>KRAS</i> G12C Colorectal Cancer.

Filippo Pietrantonio, Lisa Salvatore, Taito Esaki

|Mar 21, 2025
Response to anti-EGFR therapy in chemo-refractory right-sided RAS wild-type metastatic colorectal cancer: a case report and literature review.

Annie Xiao, Marwan Fakih

|Feb 10, 2025
Sex and outcomes of patients with microsatellite instability-high and <i>BRAF</i> V600E mutated metastatic colorectal cancer receiving immune checkpoint inhibitors.

Vincenzo Nasca, Joseph Zhao, Javier Ros

Pageof 5

Frequent Collaborators

5 joint publications

Chongkai Wang

4 joint publications

Scott Kopetz

3 joint publications

Julien Taieb

3 joint publications

Mustafa Raoof

3 joint publications

Thierry André

3 joint publications

Filippo Pietrantonio

3 joint publications

Michael J Overman

2 joint publications

Isa Mambetsariev

2 joint publications

Ravi Salgia

2 joint publications

Martin Sattler

Frequent Collaborators

5 joint publications

Chongkai Wang

4 joint publications

Scott Kopetz

3 joint publications

Julien Taieb

3 joint publications

Mustafa Raoof